Literature DB >> 9609427

Endoscopic retrograde cholangiopancreatography under general anesthesia: indications and results.

K P Etzkorn1, F Diab, R D Brown, G Dodda, B Edelstein, R Bedford, R P Venu.   

Abstract

BACKGROUND: Conscious sedation is usually used during endoscopic retrograde cholangiopancreatography (ERCP). Little is known about the indications and outcomes for ERCP in patients who cannot undergo conscious sedation and therefore require general anesthesia. We retrospectively evaluated the indications and outcome for patients undergoing ERCP who required general anesthesia at four teaching hospitals over a 2-year period.
METHODS: Of 1200 ERCPs performed over a 2-year period, 65 patients required general anesthesia. Retrospective chart analysis was undertaken to determine indications and outcomes of ERCP performed under general anesthesia. Eleven patients underwent sphincter of Oddi manometry.
RESULTS: The major indication for general anesthesia was substance abuse. Therapeutic intervention was successful in 45 of 48 patients; 6 of the 63 patients had complications, all mild and not related to the anesthesia. Sphincter of Oddi manometry was normal in 7 patients; 4 patients had elevated basal pressures.
CONCLUSIONS: ERCP under general anesthesia may be considered when conscious sedation fails to achieve a satisfactory level of sedation for a successful and safe ERCP. Procedure-related complication rates appear to be comparable if not lower with general anesthesia.

Entities:  

Mesh:

Year:  1998        PMID: 9609427     DOI: 10.1016/s0016-5107(98)70219-6

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  8 in total

1.  Deep sedation without intubation for ERCP is appropriate in healthier, non-obese patients.

Authors:  Sheila Ryan Barnett; Tyler Berzin; Sirish Sanaka; Douglas Pleskow; Mandeep Sawhney; Ram Chuttani
Journal:  Dig Dis Sci       Date:  2013-07-23       Impact factor: 3.199

2.  Deep sedation for endoscopic retrograde cholangiopacreatography.

Authors:  Irene G Chainaki; Maria M Manolaraki; Gregorios A Paspatis
Journal:  World J Gastrointest Endosc       Date:  2011-02-16

3.  A retrospective analysis of benzodiazepine sedation vs. propofol anaesthesia in 252 patients undergoing endoscopic retrograde cholangiopancreatography.

Authors:  Jeffrey T Lordan; Justin Woods; Peter Keeling; Iain M Paterson
Journal:  HPB (Oxford)       Date:  2011-01-25       Impact factor: 3.647

4.  Efficacy and Safety of Propofol-Mediated Sedation for Outpatient Endoscopic Retrograde Cholangiopancreatography (ERCP).

Authors:  Juliana F Yang; Priya Farooq; Kate Zwilling; Devi Patel; Ali A Siddiqui
Journal:  Dig Dis Sci       Date:  2016-01-29       Impact factor: 3.199

5.  A randomized controlled trial comparing gastro-laryngeal tube with endotracheal intubation for airway management in patients undergoing ERCP under general anaesthesia.

Authors:  Deepak K Sreevastava; R N Verma; Ravi Verma
Journal:  Med J Armed Forces India       Date:  2018-03-05

6.  Outpatient endoscopic retrograde cholangiopancreatography: Safety and efficacy of anesthetic management with a natural airway in 653 consecutive procedures.

Authors:  Basavana G Goudra; Preet Mohinder Singh; Ashish C Sinha
Journal:  Saudi J Anaesth       Date:  2013-07

7.  A comparison between non-sedation and general endotracheal anesthesia for retrograde endoscopic common bile duct stone removal: A tertiary center experience.

Authors:  Chih-Ming Liang; Chung-Mou Kuo; Lung-Sheng Lu; Cheng-Kun Wu; Cheng-En Tsai; Ming-Te Kuo; Yi-Chun Chiu; Wen-Chen Tai; Yuan-Hung Kuo; Chung-Huang Kuo; Seng-Kee Chuah; Chi-Sin Changchien
Journal:  Biomed J       Date:  2019-05-07       Impact factor: 4.910

Review 8.  Medical, Political, and Economic Considerations for the Use of MAC for Endoscopic Sedation: Big Price, Little Justification?

Authors:  Basavana Goudra; Preet Mohinder Singh; Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2020-09       Impact factor: 3.487

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.